{
  "dataset_id": "ds003194",
  "num_citations": 3,
  "date_last_updated": "2025-07-26T18:48:08.764106+00:00",
  "metadata": {
    "total_cumulative_citations": 27,
    "fetch_date": "2025-07-26T18:48:08.764106+00:00",
    "processing_version": "1.0"
  },
  "citation_details": [
    {
      "title": "Tools for importing and evaluating BIDS-EEG formatted data",
      "author": "A Delorme, D Truong",
      "venue": "2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)",
      "year": 2021,
      "url": "https://ieeexplore.ieee.org/abstract/document/9441399/",
      "cited_by": 13,
      "abstract": "This article outlines a set of plug-in tools running on MATLAB to automatically import, preprocess,  and evaluate the quality of electro-encephalography (EEG) data stored using the Brain",
      "short_author": "A Delorme, D Truong",
      "pages": "210--213",
      "pub_type": "inproceedings",
      "bib_id": "delorme2021tools"
    },
    {
      "title": "Causal Analysis of the Effect of NeuroEPO on Motor Performance in Parkinson's Disease: Secondary Analysis of a Randomized Controlled Study",
      "author": "ML Bringas Vega, FA Razzaq, L Shengnan, MG Llano",
      "venue": "NA",
      "year": 0,
      "url": "https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4966719",
      "cited_by": 0,
      "abstract": "Background NeuroEPO is a novel formulation of the neuroprotective cytokine Erythropoietin  (EPO) designed to minimize the hematopoietic side effects of EPO while preserving its",
      "short_author": "ML Bringas Vega, FA Razzaq, L Shengnan, MG Llano"
    },
    {
      "title": "The Effect of Neuroepo on Cognition in Parkinson’s Disease Patients Is Mediated by Electroencephalogram Source Activity",
      "author": "ML Bringas Vega, I Pedroso Ibáñez",
      "venue": "Frontiers in Neuroscience",
      "year": 2022,
      "url": "https://www.frontiersin.org/articles/10.3389/fnins.2022.841428/full",
      "cited_by": 14,
      "abstract": "We report on the quantitative electroencephalogram (qEEG) and cognitive effects of Neuroepo  in Parkinson’s disease (PD) from a double-blind safety trial ( https://clinicaltrials.gov/ ,",
      "short_author": "ML Bringas Vega, I Pedroso Ibáñez",
      "publisher": "Frontiers Media SA",
      "pages": "841428",
      "volume": "16",
      "journal": "Frontiers in Neuroscience",
      "pub_type": "article",
      "bib_id": "bringas2022effect"
    }
  ]
}